• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种模型,用于对 4536 例 COVID-19 患者的住院风险进行个体化预测。

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.

机构信息

Neurological Institute, Chief Research Information Officer, Cleveland Clinic, Cleveland, Ohio, United States of America.

Quantitative Health Science Department, Lerner Research Institute Cleveland Clinic, Cleveland, Ohio, United States of America.

出版信息

PLoS One. 2020 Aug 11;15(8):e0237419. doi: 10.1371/journal.pone.0237419. eCollection 2020.

DOI:10.1371/journal.pone.0237419
PMID:32780765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7418996/
Abstract

BACKGROUND

Coronavirus Disease 2019 is a pandemic that is straining healthcare resources, mainly hospital beds. Multiple risk factors of disease progression requiring hospitalization have been identified, but medical decision-making remains complex.

OBJECTIVE

To characterize a large cohort of patients hospitalized with COVID-19, their outcomes, develop and validate a statistical model that allows individualized prediction of future hospitalization risk for a patient newly diagnosed with COVID-19.

DESIGN

Retrospective cohort study of patients with COVID-19 applying a least absolute shrinkage and selection operator (LASSO) logistic regression algorithm to retain the most predictive features for hospitalization risk, followed by validation in a temporally distinct patient cohort. The final model was displayed as a nomogram and programmed into an online risk calculator.

SETTING

One healthcare system in Ohio and Florida.

PARTICIPANTS

All patients infected with SARS-CoV-2 between March 8, 2020 and June 5, 2020. Those tested before May 1 were included in the development cohort, while those tested May 1 and later comprised the validation cohort.

MEASUREMENTS

Demographic, clinical, social influencers of health, exposure risk, medical co-morbidities, vaccination history, presenting symptoms, medications, and laboratory values were collected on all patients, and considered in our model development.

RESULTS

4,536 patients tested positive for SARS-CoV-2 during the study period. Of those, 958 (21.1%) required hospitalization. By day 3 of hospitalization, 24% of patients were transferred to the intensive care unit, and around half of the remaining patients were discharged home. Ten patients died. Hospitalization risk was increased with older age, black race, male sex, former smoking history, diabetes, hypertension, chronic lung disease, poor socioeconomic status, shortness of breath, diarrhea, and certain medications (NSAIDs, immunosuppressive treatment). Hospitalization risk was reduced with prior flu vaccination. Model discrimination was excellent with an area under the curve of 0.900 (95% confidence interval of 0.886-0.914) in the development cohort, and 0.813 (0.786, 0.839) in the validation cohort. The scaled Brier score was 42.6% (95% CI 37.8%, 47.4%) in the development cohort and 25.6% (19.9%, 31.3%) in the validation cohort. Calibration was very good. The online risk calculator is freely available and found at https://riskcalc.org/COVID19Hospitalization/.

LIMITATION

Retrospective cohort design.

CONCLUSION

Our study crystallizes published risk factors of COVID-19 progression, but also provides new data on the role of social influencers of health, race, and influenza vaccination. In a context of a pandemic and limited healthcare resources, individualized outcome prediction through this nomogram or online risk calculator can facilitate complex medical decision-making.

摘要

背景

2019 年冠状病毒病是一种大流行疾病,正在严重消耗医疗资源,尤其是医院床位。目前已经确定了多种需要住院治疗的疾病进展的风险因素,但医疗决策仍然很复杂。

目的

描述一组因 COVID-19 住院的大量患者及其结局,开发并验证一种统计模型,以便对新诊断为 COVID-19 的患者的未来住院风险进行个体化预测。

设计

对 2020 年 3 月 8 日至 6 月 5 日期间感染 SARS-CoV-2 的患者进行回顾性队列研究,应用最小绝对收缩和选择算子(LASSO)逻辑回归算法保留与住院风险相关的最具预测性特征,然后在时间上不同的患者队列中进行验证。最终模型以诺模图的形式呈现,并编程为在线风险计算器。

地点

俄亥俄州和佛罗里达州的一个医疗系统。

参与者

2020 年 3 月 8 日至 6 月 5 日期间所有 SARS-CoV-2 检测呈阳性的患者。在 5 月 1 日之前接受检测的患者被纳入开发队列,而在 5 月 1 日及之后接受检测的患者被纳入验证队列。

测量

收集所有患者的人口统计学、临床、健康社会影响因素、暴露风险、合并症、疫苗接种史、症状、药物和实验室值,并在模型开发中进行考虑。

结果

在研究期间,有 4536 名患者的 SARS-CoV-2 检测呈阳性。其中,958 人(21.1%)需要住院治疗。住院第 3 天,24%的患者转入重症监护病房,其余患者中约有一半出院回家。有 10 名患者死亡。年龄较大、黑人、男性、吸烟史、糖尿病、高血压、慢性肺部疾病、较差的社会经济地位、呼吸急促、腹泻以及某些药物(非甾体抗炎药、免疫抑制治疗)会增加住院风险。流感疫苗接种可降低住院风险。在开发队列中,该模型的区分度非常好,曲线下面积为 0.900(95%置信区间为 0.886-0.914),在验证队列中为 0.813(0.786,0.839)。开发队列中的缩放 Brier 评分(衡量模型准确性的指标)为 42.6%(95%置信区间为 37.8%,47.4%),验证队列为 25.6%(19.9%,31.3%)。校准效果非常好。在线风险计算器可免费使用,并可在 https://riskcalc.org/COVID19Hospitalization/ 找到。

局限性

回顾性队列设计。

结论

我们的研究明确了 COVID-19 进展的已发表风险因素,但也提供了有关健康、种族和流感疫苗接种的社会影响因素的新数据。在大流行和有限的医疗资源背景下,通过该诺模图或在线风险计算器进行个体化预后预测,可以帮助进行复杂的医疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d14d8781377c/pone.0237419.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/2ad0abf268f9/pone.0237419.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d27742fcb779/pone.0237419.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d82eecff2a98/pone.0237419.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d14d8781377c/pone.0237419.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/2ad0abf268f9/pone.0237419.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d27742fcb779/pone.0237419.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d82eecff2a98/pone.0237419.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ed/7418996/d14d8781377c/pone.0237419.g004.jpg

相似文献

1
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.开发和验证一种模型,用于对 4536 例 COVID-19 患者的住院风险进行个体化预测。
PLoS One. 2020 Aug 11;15(8):e0237419. doi: 10.1371/journal.pone.0237419. eCollection 2020.
2
Individualizing Risk Prediction for Positive Coronavirus Disease 2019 Testing: Results From 11,672 Patients.个体化新型冠状病毒肺炎检测阳性风险预测:来自 11672 例患者的结果。
Chest. 2020 Oct;158(4):1364-1375. doi: 10.1016/j.chest.2020.05.580. Epub 2020 Jun 10.
3
Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients.建立 ICU 转科或死亡的多变量预测模型:一项法国前瞻性队列研究COVID-19 住院患者。
PLoS One. 2020 Oct 19;15(10):e0240711. doi: 10.1371/journal.pone.0240711. eCollection 2020.
4
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
5
Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan, China.开发和验证预测严重 COVID-19 风险的列线图:来自中国四川的一项多中心研究。
PLoS One. 2020 May 18;15(5):e0233328. doi: 10.1371/journal.pone.0233328. eCollection 2020.
6
Exploiting an early warning Nomogram for predicting the risk of ICU admission in patients with COVID-19: a multi-center study in China.利用早期预警列线图预测 COVID-19 患者 ICU 收治风险:一项中国多中心研究。
Scand J Trauma Resusc Emerg Med. 2020 Oct 27;28(1):106. doi: 10.1186/s13049-020-00795-w.
7
Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2.基于影像组学的 2019 年新型冠状病毒肺炎(COVID-19)严重程度预测列线图模型。
Eur Radiol. 2020 Dec;30(12):6888-6901. doi: 10.1007/s00330-020-07032-z. Epub 2020 Jul 3.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
Racial Disparities in Incidence and Outcomes Among Patients With COVID-19.COVID-19 患者的发病和结局中的种族差异。
JAMA Netw Open. 2020 Sep 1;3(9):e2021892. doi: 10.1001/jamanetworkopen.2020.21892.
10
Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.在学术医疗体系中,与新冠疫情结果的种族/民族差异相关的特征。
JAMA Netw Open. 2020 Oct 1;3(10):e2025197. doi: 10.1001/jamanetworkopen.2020.25197.

引用本文的文献

1
Development and Validation of a Novel Risk Calculator to Predict Sub-optimal HIV Outcomes Among Pregnant and Postpartum Women with HIV in Kenya.用于预测肯尼亚感染艾滋病毒的孕妇和产后妇女不良艾滋病毒结局的新型风险计算器的开发与验证
AIDS Behav. 2025 Jul 10. doi: 10.1007/s10461-025-04814-8.
2
COVID-19 Humic/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review.新冠病毒-19腐殖酸/富里酸加表没食子儿茶素没食子酸酯治疗:一项回顾性病历审查
Cureus. 2025 Jan 9;17(1):e77188. doi: 10.7759/cureus.77188. eCollection 2025 Jan.
3
Predictors of Hospitalization for Patients Presenting to Emergency Department with COVID-19 Infection.

本文引用的文献

1
Complete blood count might help to identify subjects with high probability of testing positive to SARS-CoV-2.全血细胞计数可能有助于识别出极有可能检测出 SARS-CoV-2 阳性的受试者。
Clin Med (Lond). 2020 Jul;20(4):e114-e119. doi: 10.7861/clinmed.2020-0373. Epub 2020 Jul 2.
2
Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020.美国对 2020 年 2 月 24 日至 4 月 21 日期间大流行 COVID-19 疫情的启动和传播的公共卫生应对措施。
MMWR Morb Mortal Wkly Rep. 2020 May 8;69(18):551-556. doi: 10.15585/mmwr.mm6918e2.
3
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.
因新冠病毒感染前往急诊科就诊患者的住院预测因素。
J Clin Med. 2025 Jan 10;14(2):413. doi: 10.3390/jcm14020413.
4
Artificial intelligence for predicting mortality in hospitalized COVID-19 patients.用于预测新冠肺炎住院患者死亡率的人工智能
Digit Health. 2024 Oct 3;10:20552076241287919. doi: 10.1177/20552076241287919. eCollection 2024 Jan-Dec.
5
Machine Learning Predicts Unplanned Care Escalations for Post-Anesthesia Care Unit Patients during the Perioperative Period: A Single-Center Retrospective Study.机器学习预测围手术期术后恢复室患者非计划性护理升级:单中心回顾性研究。
J Med Syst. 2024 Jul 23;48(1):69. doi: 10.1007/s10916-024-02085-9.
6
Evolution of serious and life-threatening COVID-19 pneumonia as the SARS-CoV-2 pandemic progressed: an observational study of mortality to 60 days after admission to a 15-hospital US health system.严重和危及生命的 COVID-19 肺炎在 SARS-CoV-2 大流行期间的演变:对一家拥有 15 家医院的美国卫生系统住院后 60 天内死亡率的观察性研究。
BMJ Open. 2024 Jul 8;14(7):e075028. doi: 10.1136/bmjopen-2023-075028.
7
Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.使用机器学习预测奥密克戎毒株流行期间新冠病毒感染的临床结局
PLoS One. 2024 Apr 25;19(4):e0290221. doi: 10.1371/journal.pone.0290221. eCollection 2024.
8
A systematic review of tools for predicting complications in patients with influenza-like illness.对预测流感样疾病患者并发症的工具进行的系统评价。
Heliyon. 2023 Dec 3;10(1):e23227. doi: 10.1016/j.heliyon.2023.e23227. eCollection 2024 Jan 15.
9
Use of a rapid triage assessment tool to discriminate the need for hospitalisation in patients with severe COVID-19 infection presenting to an outpatient clinic: a single-centre, prospective cohort study.使用快速分诊评估工具来区分因严重 COVID-19 感染而到门诊就诊的患者是否需要住院治疗:一项单中心前瞻性队列研究。
BMJ Open. 2023 Nov 29;13(11):e073781. doi: 10.1136/bmjopen-2023-073781.
10
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study.新型冠状病毒肺炎风险预测模型的验证:PERIL前瞻性队列研究
Future Virol. 2023 Oct. doi: 10.2217/fvl-2023-0036. Epub 2023 Nov 7.
2020 年 3 月 1 日至 30 日,14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
4
Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.COVID-19 快速监测 - 加利福尼亚州圣克拉拉县,2020 年 3 月。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):419-421. doi: 10.15585/mmwr.mm6914e3.
5
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
6
Clinical progression of patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者的临床进展。
J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19.
7
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
8
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.分析与 2019 年新型冠状病毒病住院患者疾病结局相关的因素。
Chin Med J (Engl). 2020 May 5;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.
9
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
10
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎(SARS-CoV-2)感染的癌症患者:一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.